Today's decision by the FDA offers hope for the millions of adults living with both conditions and provides an additional treatment option, representing a significant advancement for my patients." - Richard E
Because obesity has been a challenge for many, and so few medications help with weight loss, the drug has taken the world by storm
The FDA and other policymakers should take immediate action to ensure the integrity of the FDA's rigorous regulatory review and approval process, the drug supply chain and decades of carefully balanced approaches to fostering innovation and generic competition. Eli Lilly, Novo Nordisks rival in the diabetes and obesity market, also is expected to launch a weight-loss pill, orforglipron, in the first half of this year
Your provider will look at your entire health profile to see which one aligns best with your needs
Coordinate your semaglutide dose with other weekly activities you never miss, such as a work meeting or religious service